BioMark Diagnostics Inc. (BMKDF)
USD 0.18
(0.0%)
USD 0.18
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 805.93 Thousand CAD | -2.18% |
| 2023 | 823.87 Thousand CAD | -21.49% |
| 2022 | 1.04 Million CAD | 779.45% |
| 2021 | 119.32 Thousand CAD | 1277.24% |
| 2020 | 8664.00 CAD | 0.0% |
| 2019 | - CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 983.56 Thousand CAD | 135.48% |
| 2024 Q1 | 640.13 Thousand CAD | -22.3% |
| 2024 Q2 | 417.68 Thousand CAD | -34.75% |
| 2024 Q4 | 805.93 Thousand CAD | -18.06% |
| 2024 FY | 805.93 Thousand CAD | -2.18% |
| 2023 FY | 823.87 Thousand CAD | -21.49% |
| 2023 Q3 | 908.29 Thousand CAD | -8.37% |
| 2023 Q4 | 823.87 Thousand CAD | -9.3% |
| 2023 Q2 | 991.24 Thousand CAD | 1.1% |
| 2023 Q1 | 980.49 Thousand CAD | -6.57% |
| 2022 Q3 | 969.82 Thousand CAD | 733.47% |
| 2022 Q1 | 117.84 Thousand CAD | -1.24% |
| 2022 FY | 1.04 Million CAD | 779.45% |
| 2022 Q4 | 1.04 Million CAD | 8.2% |
| 2022 Q2 | 116.36 Thousand CAD | -1.26% |
| 2021 Q4 | 119.32 Thousand CAD | 19.32% |
| 2021 FY | 119.32 Thousand CAD | 1277.24% |
| 2021 Q1 | 5000.00 CAD | -42.29% |
| 2021 Q3 | 100 Thousand CAD | 23.06% |
| 2021 Q2 | 81.26 Thousand CAD | 1525.26% |
| 2020 FY | 8664.00 CAD | 0.0% |
| 2020 Q4 | 8664.00 CAD | -99.08% |
| 2020 Q3 | 945.5 Thousand CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q4 | - CAD | -100.0% |
| 2019 FY | - CAD | 0.0% |
| 2019 Q3 | 1 Million CAD | 12.75% |
| 2019 Q2 | 894.74 Thousand CAD | 4.36% |
| 2019 Q1 | 857.38 Thousand CAD | 0.0% |
| 2018 Q1 | 783.16 Thousand CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q4 | - CAD | -100.0% |
| 2018 Q3 | 695.4 Thousand CAD | 6.07% |
| 2018 Q2 | 655.59 Thousand CAD | -16.29% |
| 2017 Q2 | 551.88 Thousand CAD | 29.66% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | -100.0% |
| 2017 Q1 | 425.62 Thousand CAD | 0.0% |
| 2016 Q2 | 221.69 Thousand CAD | 55.76% |
| 2016 Q1 | 142.33 Thousand CAD | 0.0% |
| 2016 Q3 | 335.67 Thousand CAD | 51.41% |
| 2016 FY | - CAD | 0.0% |
| 2016 Q4 | - CAD | -100.0% |
| 2015 Q4 | - CAD | -100.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q3 | 114.09 Thousand CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | 64.021% |
| Arrayit Corporation | 1.07 Million USD | 25.25% |
| Atlantic International Corp. | 2.93 Million USD | 72.498% |
| Biocept, Inc. | 12.1 Million USD | 93.344% |
| Bioqual, Inc. | 3.58 Million USD | 77.532% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -1009.884% |
| DermTech, Inc. | 54.39 Million USD | 98.518% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 99.829% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | 83.328% |
| iMD Companies, Inc. | 1.12 Million USD | 28.051% |
| IDenta Corp. | 789.14 Thousand USD | -2.127% |
| Interpace Biosciences, Inc. | 11.19 Million USD | 92.799% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -1738.137% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | 89.982% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | 78.935% |
| NovelStem International Corp. | 3.57 Million USD | 77.454% |
| Optigenex Inc. | 8.94 Million USD | 90.986% |
| PharmChem, Inc. | 77.35 Thousand USD | -941.887% |
| Proteome Sciences plc | 17.15 Million USD | 95.302% |
| Response Genetics, Inc | 6.37 Million USD | 87.354% |
| Rennova Health, Inc. | 15.32 Million USD | 94.743% |
| RushNet, Inc. | 4.82 Million USD | 83.29% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -289.275% |
| Stella Diagnostics Inc. | 6.2 Million USD | 87.003% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | 55.228% |
| Todos Medical Ltd. | 38.34 Million USD | 97.898% |